# Treatment of Anemic Patients With Cancer Who Are Not Receiving Chemotherapy or Radiotherapy

> **NCT00083434** · PHASE3 · TERMINATED · sponsor: **Johnson & Johnson Pharmaceutical Research & Development, L.L.C.**

## Conditions studied

- Anemia
- Cancer

## Interventions

- **DRUG:** Epoetin alfa

## Key facts

- **NCT ID:** NCT00083434
- **Lead sponsor:** Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2004-02
- **Primary completion:** —
- **Final completion:** 2004-10
- **Target enrollment:** — (—)
- **Why stopped:** This study was stopped because of an inadequate rate of enrollment.
- **Last updated:** 2011-04-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00083434

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00083434, "Treatment of Anemic Patients With Cancer Who Are Not Receiving Chemotherapy or Radiotherapy". Retrieved via AI Analytics 2026-07-08 from https://api.ai-analytics.org/clinical/NCT00083434. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*